Small cap opportunity: Lexaria Bioscience Corp. | Improving Absorption of Medical Cannabinoids
Patented technology to improve absorption and potency of products as vitamins and pain relievers.
Focused above all on generating revenue through out-licensing its technology internationally. Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds.
The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also improving taste.
This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery.
Subscribe to receive more investment opportunities videos: http://bit.ly/Subscribe2BTV